 |
 |
 |
 |
 |
 |
 |
|
|
 |
  |
 |
 |
 |
 |
 |
 |
 |
 |
| Medical Advisors |
 |
Maurizio Fava, MD, Director, Clinical Research Program, Executive Vice Chair, Department of Psychiatry, Executive Director, Clinical Trials Network & Institute Professor, Harvard Medical School
Michael E. Henry, MD, Medical Director, The Bipolar Clinic & Research Program, Massachusetts General Hospital Kevin Kinback, MD, Psychiatrist, TMS Specialist, Assistant Clinical Professor of Psychiatry, Loma Linda University Andrew Nierenberg, MD, Director, Bipolar Clinic and Research Program, Associate Director, Depression Clinical and Research Program, Director, Clinical Research Support Office, Clinical Research Program George Papakostas, MD, Scientific Director of the Massachusetts General Hospital Clinical Trials Network and Institute, Director of Treatment-Resistant Depression Studies in the Department of Psychiatry at MGH, and Associate Professor of Psychiatry at Harvard Medical School John Powderly, MD, Founder, Carolina BioOncology Institute (CBI), a cancer therapy and research center. Triple Board Certified in Internal Medicine, Pediatrics, and Adult Medical Oncology Richard C. Shelton, MD, Charles B. Ireland Professor of Psychiatry & Vice Chair for Research Department of Psychiatry and Behavioral Neurobiology and Head of the Mood Disorders Research Center, University of Alabama Joseph Shurman, MD, Chairman, Pain Management Scripps Memorial Hospital La Jolla, CA, Clinical Assistant Professor at the University of California, San Diego, founder of the Share the Risk model
|
